Synthesis and evaluation of dual crosslinked alginate microbeads

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Polymer Chemistry

Background:

• Alginate hydrogels are widely used for cell encapsulation, particularly for islet transplantation in type 1 diabetes treatment.
• Current alginate systems face challenges with poor mechanical stability and premature breakdown after implantation.
• Improved microcapsule integrity is crucial for long-term function and preventing adverse immunological reactions.

Purpose of the Study:

• To enhance the stability of alginate hydrogels for cell encapsulation.
• To develop a dual crosslinking strategy for alginate microbeads using photoactivatable groups.
• To evaluate the in vitro and in vivo performance of modified alginate microbeads.

Main Methods:

• Alginate was modified with 2-aminoethyl methacrylate hydrochloride (AEMA) to introduce photoactivatable groups.
• Dual crosslinked alginate microbeads were formed via initial ionic crosslinking followed by UV-induced covalent crosslinking.
• In vitro stability, swelling, and cell viability were assessed, alongside in vivo implantation in a rat model with induced inflammation.

Main Results:

• Methacrylated alginate resulted in more stable microbeads compared to unmodified alginate.
• Cells encapsulated within the modified alginate beads maintained viability.
• Dual crosslinked alginate microbeads demonstrated significant stability up to 3 weeks post-implantation, while unmodified beads failed by week 1.

Conclusions:

• Dual crosslinking of alginate via photoactivatable modification significantly improves microcapsule stability in vivo.
• This enhanced stability addresses a key challenge in alginate-based cell encapsulation systems.
• Modified alginate microbeads represent a promising alternative for more durable cell delivery applications.